These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 23363720)

  • 1. [Impact of multifactor intensive intervention on self management, risk factor control and outcome of post percutaneous transluminal coronary intervention patients].
    He YP; Lu ZG; Gu YW; Pan JW; Gao MF; Wei M
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Dec; 40(12):1037-40. PubMed ID: 23363720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefit of post PCI medical checklist to improve adhering with best practice guidelines in the patients with coronary artery disease undergoing percutaneous coronary intervention (PCI).
    Phed-on U; Naowapanich S; Poolsawat U; Nimmannit A; Wongpraparut N
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S1-10. PubMed ID: 21728269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive nursing care by an electronic followup system to promote secondary prevention after percutaneous coronary intervention: a randomized trial.
    Hu X; Zhu X; Gao L
    J Cardiopulm Rehabil Prev; 2014; 34(6):396-405. PubMed ID: 24667664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-year results of a controlled study of residential rehabilitation for patients treated with percutaneous transluminal coronary angioplasty. A randomized study of a multifactorial programme.
    Hofman-Bang C; Lisspers J; Nordlander R; Nygren A; Sundin O; Ohman A; Rydén L
    Eur Heart J; 1999 Oct; 20(20):1465-74. PubMed ID: 10493845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of statins prior to percutaneous coronary intervention reduces myonecrosis and improves clinical outcome.
    Chang SM; Yazbek N; Lakkis NM
    Catheter Cardiovasc Interv; 2004 Jun; 62(2):193-7. PubMed ID: 15170709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of antiplatelet efficacy and tolerability of clopidogrel napadisilate with clopidogrel bisulfate in coronary artery disease patients after percutaneous coronary intervention: a prospective, multicenter, randomized, open-label, phase IV, noninferiority trial.
    Park JB; Koo BK; Choi WG; Kim SY; Park J; Kwan J; Park CG; Kim HS
    Clin Ther; 2013 Jan; 35(1):28-37.e4. PubMed ID: 23328268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and feasibility of early hospital discharge in ST-segment elevation myocardial infarction--a prospective and randomized trial in low-risk primary percutaneous coronary intervention patients (the Safe-Depart Trial).
    Kotowycz MA; Cosman TL; Tartaglia C; Afzal R; Syal RP; Natarajan MK
    Am Heart J; 2010 Jan; 159(1):117.e1-6. PubMed ID: 20102876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of percutaneous coronary intervention with medication in the treatment of coronary artery disease in hemodialysis patients.
    Yasuda K; Kasuga H; Aoyama T; Takahashi H; Toriyama T; Kawade Y; Iwashima S; Yamada S; Kawahara H; Maruyama S; Yuzawa Y; Ishii H; Murohara T; Matsuo S
    J Am Soc Nephrol; 2006 Aug; 17(8):2322-32. PubMed ID: 16837633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence, predictors, and outcomes of post-percutaneous coronary intervention nephropathy in patients with diabetes mellitus and normal baseline serum creatinine levels.
    Roy P; Raya V; Okabe T; Pinto Slottow TL; Steinberg DH; Smith K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2008 Jun; 101(11):1544-9. PubMed ID: 18489931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of treating exhaustion in angioplasty patients on new coronary events: results of the randomized Exhaustion Intervention Trial (EXIT).
    Appels A; Bär F; van der Pol G; Erdman R; Assman M; Trijsburg W; van Diest R; van Dixhoorn J; Mendes de Leon C
    Psychosom Med; 2005; 67(2):217-23. PubMed ID: 15784786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal medical therapy with or without percutaneous coronary intervention for patients with stable coronary artery disease and chronic kidney disease.
    Sedlis SP; Jurkovitz CT; Hartigan PM; Goldfarb DS; Lorin JD; Dada M; Maron DJ; Spertus JA; Mancini GB; Teo KK; O'Rourke RA; Boden WE; Weintraub WS;
    Am J Cardiol; 2009 Dec; 104(12):1647-53. PubMed ID: 19962469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coaching patients On Achieving Cardiovascular Health (COACH): a multicenter randomized trial in patients with coronary heart disease.
    Vale MJ; Jelinek MV; Best JD; Dart AM; Grigg LE; Hare DL; Ho BP; Newman RW; McNeil JJ;
    Arch Intern Med; 2003 Dec 8-22; 163(22):2775-83. PubMed ID: 14662633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Follow-up study of programmed intervention of hyperuricemia in the prevention and treatment of cardiovascular morbid change].
    Zhu WH; Fang LZ; Chen LY; Chen ZW; Dai HL; Chen JH
    Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(10):662-6. PubMed ID: 20450723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risk modification in participants with coronary disease screened by the Kidney Early Evaluation Program.
    McCullough PA; Whaley-Connell A; Brown WW; Collins AJ; Chen SC; Li S; Norris KC; Jurkovitz C; McFarlane S; Obialo C; Sowers J; Stevens L; Vassalotti JA; Bakris GL;
    Intern Med J; 2010 Dec; 40(12):833-41. PubMed ID: 21199222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and effectiveness of a selective strategy for coronary artery revascularization before transcatheter aortic valve implantation.
    Gasparetto V; Fraccaro C; Tarantini G; Buja P; D'Onofrio A; Yzeiraj E; Pittarello D; Isabella G; Gerosa G; Iliceto S; Napodano M
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):376-83. PubMed ID: 22461314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is evaluation of complex polymorphism helpful in the assessment of prognosis after percutaneous coronary intervention. A prospective study.
    Rywik TM; Szperl M; Płoski R; Leszek P; Roszczynko M; Rynkun D; Witkowski A; Kurjata P; Korewicki J
    Kardiol Pol; 2011; 69(9):881-8. PubMed ID: 21928191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous coronary intervention among patients with left ventricular systolic dysfunction: a review and meta-analysis of 19 clinical studies.
    Kunadian V; Pugh A; Zaman AG; Qiu W
    Coron Artery Dis; 2012 Nov; 23(7):469-79. PubMed ID: 22960383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction.
    Sorajja P; Gersh BJ; Cox DA; McLaughlin MG; Zimetbaum P; Costantini C; Stuckey T; Tcheng JE; Mehran R; Lansky AJ; Grines CL; Stone GW
    Eur Heart J; 2007 Jul; 28(14):1709-16. PubMed ID: 17556348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term outcome analysis of patients underwent percutaneous coronary intervention with prior ischemic stroke].
    Han YC; Zhang SY; Lin SB; Shen ZJ; Fan ZJ; Wang CH; Jin XF; Xie HZ; Liu ZY; Zeng Y; Fang Q
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Nov; 39(11):980-3. PubMed ID: 22336447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.